De-escalation yes, but not at the expense of efficacy: in defense of better treatment

por Shapiro, Charles L.
Publicado 2019

Caring about bone-modifying agents (BMAs) in women with early-stage breast cancer

por Shapiro, Charles L.
Publicado 2020

Osteoporosis: A Long-Term and Late-Effect of Breast Cancer Treatments

por Shapiro, Charles L.
Publicado 2020

Clinical outcomes of de novo metastatic HER2-low breast cancer: a National Cancer Database Analysis

por Jiang, Changchuan, Perimbeti, Stuthi, Deng, Lei, Shapiro, Charles L., Gandhi, Shipra
Publicado 2022

Effect of Foliar Micronutrients (B, Mn, Fe, Zn) on Maize Grain Yield, Micronutrient Recovery, Uptake, and Partitioning

por Stewart, Zachary P., Paparozzi, Ellen T., Wortmann, Charles S., Jha, Prakash Kumar, Shapiro, Charles A.
Publicado 2021

Oncotype Dx Score, HER2 Low Expression, and Clinical Outcomes in Early-Stage Breast Cancer: A National Cancer Database Analysis

por Roy, Arya Mariam, Jiang, Changchuan, Perimbeti, Stuthi, Deng, Lei, Shapiro, Charles L., Gandhi, Shipra
Publicado 2023

Identifying survival associated morphological features of triple negative breast cancer using multiple datasets

por Wang, Chao, Pécot, Thierry, Zynger, Debra L, Machiraju, Raghu, Shapiro, Charles L, Huang, Kun
Publicado 2013

Epigenetic Repression of RARRES1 Is Mediated by Methylation of a Proximal Promoter and a Loss of CTCF Binding

por Peng, Zhengang, Shen, Rulong, Li, Ying-Wei, Teng, Kun-Yu, Shapiro, Charles L., Lin, Huey-Jen L.
Publicado 2012

Feasibility of stopping paclitaxel premedication after two doses in patients not experiencing a previous infusion hypersensitivity reaction

por Berger, Michael J., Dunlea, Leslie J., Rettig, Amy E., Lustberg, Maryam B., Phillips, Gary S., Shapiro, Charles L.
Publicado 2011

Fatty acid binding protein 5 promotes metastatic potential of triple negative breast cancer cells through enhancing epidermal growth factor receptor stability

por Powell, Catherine A., Nasser, Mohd W., Zhao, Helong, Wochna, Jacob C., Zhang, Xiaoli, Shapiro, Charles, Shilo, Konstantin, Ganju, Ramesh K.
Publicado 2015

Phase I dose escalation pharmacokinetic assessment of intravenous humanized anti-MUC1 antibody AS1402 in patients with advanced breast cancer

por Pegram, Mark D, Borges, Virginia F, Ibrahim, Nuhad, Fuloria, Jyotsna, Shapiro, Charles, Perez, Susan, Wang, Karen, Schaedli Stark, Franziska, Courtenay Luck, Nigel
Publicado 2009

microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers

por Gasparini, Pierluigi, Cascione, Luciano, Fassan, Matteo, Lovat, Francesca, Guler, Gulnur, Balci, Serdar, Irkkan, Cigdem, Morrison, Carl, Croce, Carlo M., Shapiro, Charles L., Huebner, Kay
Publicado 2014

Integrated MicroRNA and mRNA Signatures Associated with Survival in Triple Negative Breast Cancer

por Cascione, Luciano, Gasparini, Pierluigi, Lovat, Francesca, Carasi, Stefania, Pulvirenti, Alfredo, Ferro, Alfredo, Alder, Hansjuerg, He, Gang, Vecchione, Andrea, Croce, Carlo M., Shapiro, Charles L., Huebner, Kay
Publicado 2013

Stem cell-related markers in primary breast cancers and associated metastatic lesions

por Guler, Gulnur, Balci, Serdar, Costinean, Stefan, Ussakli, Cigdem Himmetoglu, Irkkan, Cigdem, Suren, Dinc, Sari, Ebru, Altundag, Kadri, Ozisik, Yavuz, Jones, Susie, Bacher, Jason, Shapiro, Charles L., Huebner, Kay
Publicado 2012

Function of Integrin-Linked Kinase in Modulating the Stemness of IL-6–Abundant Breast Cancer Cells by Regulating γ-Secretase–Mediated Notch1 Activation in Caveolae()()

por Hsu, En-Chi, Kulp, Samuel K., Huang, Han-Li, Tu, Huang-Ju, Salunke, Santosh B., Sullivan, Nicholas J., Sun, Duxin, Wicha, Max S., Shapiro, Charles L., Chen, Ching-Shih
Publicado 2015

Selective Roles of E2Fs for ErbB2- and Myc-mediated Mammary Tumorigenesis

por Wu, Lizhao, de Bruin, Alain, Wang, Hui, Simmons, Timothy, Cleghorn, Whitney, Goldenberg, Larry E., Sites, Emily, Sandy, April, Trimboli, Anthony, Fernandez, Soledad A., Eng, Charis, Shapiro, Charles, Leone, Gustavo
Publicado 2013

Androgen Receptor Status Is a Prognostic Marker in Non-Basal Triple Negative Breast Cancers and Determines Novel Therapeutic Options

por Gasparini, Pierluigi, Fassan, Matteo, Cascione, Luciano, Guler, Gulnur, Balci, Serdar, Irkkan, Cigdem, Paisie, Carolyn, Lovat, Francesca, Morrison, Carl, Zhang, Jianying, Scarpa, Aldo, Croce, Carlo M., Shapiro, Charles L., Huebner, Kay
Publicado 2014

The prevalence of BRCA1 mutations among young women with triple-negative breast cancer

por Young, SR, Pilarski, Robert T, Donenberg, Talia, Shapiro, Charles, Hammond, Lyn S, Miller, Judith, Brooks, Karen A, Cohen, Stephanie, Tenenholz, Beverly, DeSai, Damini, Zandvakili, Inuk, Royer, Robert, Li, Song, Narod, Steven A
Publicado 2009

Histone H1 Phosphorylation in Breast Cancer

por Harshman, Sean W., Hoover, Michael E., Huang, Chengsi, Branson, Owen E., Chaney, Sarah B., Cheney, Carolyn M., Rosol, Thomas J., Shapiro, Charles L., Wysocki, Vicki H., Huebner, Kay, Freitas, Michael A.
Publicado 2014

CSF1-ETS2 Induced microRNA in Myeloid Cells Promote Metastatic Tumor Growth

por Mathsyaraja, Haritha, Thies, Katie, Taffany, David A., Deighan, Clayton, Liu, Tom, Yu, Lianbo, Fernandez, Soledad A., Shapiro, Charles, Otero, Jose, Timmers, Cynthia, Lustberg, Maryam B., Chalmers, Jeffrey, Leone, Gustavo, Ostrowski, Michael C.
Publicado 2014